Showing results (701-710 of 878) with videos related to

Sort By:
Pageof 88
Clinical Radiology|September 28, 2021
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): a good practice guide, pictorial review, and new perspectivesA S Mehdi, G Bitar, R K Sharma, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2026
Neprilysin mediated cleavage of phospholamban dysregulates SERCA in heart failureJacob D Cunningham, Taylor A Phillips, Alexis R Mazzenga, et al.
Blood|May 9, 2001
Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBOP N Mainwaring, D Cunningham, W Gregory, et al.
Lancet (London, England)|March 19, 1994
Placebo-controlled phase III trial of lenograstim in bone-marrow transplantationC Gisselbrecht, H G Prentice, A Bacigalupo, et al.
O&G Open|March 2, 2026
The Case for Standardized Maternal Cardiac Arrest Simulation Training in Prehospital and Hospital-Based SettingsAndrea D Shields, Jacqueline Vidosh, Thomas W Trimarco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 14, 2011
A dose escalation study of gemcitabine plus oxaliplatin in combination with imatinib for gemcitabine-refractory advanced pancreatic adenocarcinomaN Starling, E A Hawkes, I Chau, et al.
Bone Marrow Transplantation|September 11, 1998
The importance of CD34+/CD33- cells in platelet engraftment after intensive therapy for cancer patients given peripheral blood stem cell rescueB C Millar, J L Millar, V Shepherd, et al.
Clinical Chemistry|August 1, 1978
High-performance liquid-chromatographic separation and fluorescence measurement of biogenic amines in plasma, urine, and tissueT P Davis, C W Gehrke, C W Gehrke, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 1995
'Tomudex' (ZD1694): results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia. The 'Tomudex' Colorectal Cancer Study GroupD Cunningham, J R Zalcberg, U Rath, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 14, 2008
Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority studyM L Rothenberg, J V Cox, C Butts, et al.
Pageof 88